The article presents the effects of an attempt to ascertain to what extent the Interinstitutional Agreement on a mandatory transparency register affects the phenomenon of lobbying in the European Union (EU). In order to examine the issue, the concept and essence of lobbying in the EU were introduced. Legal regulations concerning EU lobbying were also identified. A further portion of the article analyses the Interinstitutional Agreement of 20 May 2021 between the European Parliament, the Council of the European Union, and the European Commission on a mandatory transparency register (IAMTR) in relation to the previously binding Agreement between the Parliament and the European Commission on the transparency register for organisations and self-employed individuals in EU Policy-making and Policy implementation (ATR). The article uses the formal-dogmatic method. As a result of the analysis, it was concluded that the Interinstitutional Agreement on a mandatory transparency register contains numerous exclusions, both subjective and objective, to registration in the Transparency Register. One positive aspect is the application of the IAMTR to the EU Council also.
The paper constitutes an attempt at analysing the issue of misleading advertising practices for medicinal products and dietary supplements. Furthermore, the aim of the paper was to provide an answer to the question whether the binding legal regulations concerning advertisement of medicinal products and dietary supplements sufficiently protect consumers against being misled. While studying the subject topic, in particular the dogmatic research method was used, through the agency of the analysis of legal provisions referring to the indicated issue and confrontation thereof with the practice applied in advertisements of medicinal products and dietary supplements. As a result of the conducted analysis of the indicated issue a conclusion has been drawn that the use of certain advertising practices on the pharmaceutical market may mislead consumers, which has a negative impact on public health. Having in mind the need for strengthening the consumers’ protection against the unfair advertisements of medicinal products and dietary supplements, the problems have been identified and it has been proposed to introduce legal regulations aimed at improvement of the consumers’ protection against practices that may be misleading.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.